Related Experiment Videos
Intensive care experience with intravenous cimetidine
1Cullman Medical Center, AL.
Alabama Medicine : Journal of the Medical Association of the State of Alabama
|October 1, 1990
Summary
Intravenous cimetidine effectively reduced gastrointestinal symptoms and acid secretion in critically ill patients. This H2-receptor antagonist proved safe and cost-effective for those unable to take oral medications.
Area of Science:
- Gastroenterology
- Critical Care Medicine
- Pharmacology
Background:
- Critically ill patients often experience gastrointestinal distress and are at risk for stress-induced ulcers.
- Management of gastric discomfort and hemorrhage in these patients can be challenging, especially when oral administration is not feasible.